Press release – 2013
- November 27, 2013
Alethia Biotherapeutics announces the issuance of patent EP2032701 entitled “Polynucleotides and polypeptide sequences involved in cancer ” by the European Patent Office
- November 12, 2013
Alethia Biotherapeutics announces the issuance of U.S. Patent No. 8,580,257 entitled “Antibodies that specifically block the biological activity of kidney associated antigen 1 (KAAG1)” by the United States Patent and Trademark Office (“USPTO”)
- October 9, 2013
Alethia Biotherapeutics Announces the Issuance of a Patent for the Use of Anti-Siglec-15 Antibodies
- May 16, 2013
Alethia Biotherapeutics Announces the Issuance of a United States Patent for Monoclonal Antibodies Targeting Secreted Clusterin for Inhibition of EMT
- February 28, 2013
Alethia Biotherapeutics Announces Notice of Allowance of a United States Patent for Monoclonal Antibodies Targeting Secreted Clusterin for Inhibition of EMT
- February 19, 2013
Alethia Biotherapeutics Announces Issuance of a Japanese Patent for Monoclonal Antibodies Targeting Siglec-15